http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20073768-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
filingDate 2007-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49d91781d1c084802a5ffa7ed284b6fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ef93d783ab755d6d83f35ddd91b3687
publicationDate 2007-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20073768-L
titleOfInvention Transdermal patch with progesterone A-specific ligands (PRASL) as an active ingredient
abstract BACKGROUND OF THE INVENTION This invention relates to a transdermal patch of progesterone A-specific ligands (PRASL) as an active ingredient, consisting of a backing layer, at least one adhesive layer adhering thereto and containing an active ingredient and based on a silicone polymer, polyisobutylene polymer ( PIB), a polyacylate polymer or a styrene block copolymer with butadiene or isoprene (SBS or SIS) in addition to a protective film which can be taken. The invasive transdermal therapeutic patch containing PRASL, optionally combined with estrogens, is appropriate for hormone replacement therapy and fertility control.
priorityDate 2004-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456653168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407043279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6557

Total number of triples: 37.